Media coverage
3
Media coverage
Title New Phase II data indicate regimen of Truxima®... Media name/outlet ADVFN Deutschland Country/Territory Germany Date 20/6/15 URL de.advfn.com/p.php?pid=nmona&article=82654749 Persons Ki woo Kim Title New Phase II data indicate regimen of Truxima(R) (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma Media name/outlet TD Ameritrade Country/Territory United States Date 20/6/15 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-166b5470 Persons Ki woo Kim Title New Phase II data indicate regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in rel Media name/outlet Acrofan Date 20/6/14 URL https://us.acrofan.com/detail.php?number=295529 Persons Ki woo Kim